This difference may suggest a more rapid attenuation of liraglutide in non-Asian patients
Its a partnership
the peptide Ac-Nle-cyc/o(- Asp-His-D-Phe-Arg-Trp-Lys)-OH is used for the manufacture of a medicament for treatment by multiple agent therapy with a PDE-5 inhibitor for sexual dysfunction, wherein the amount of each of the peptide Ac-Nle-cyc/o(-Asp-His-D-Phe-Arg-Trp-Lys)-OH and the PDE-5 inhibitor is not sufficient, if administered as monotherapy, to independently initiate the desired pharmacological response in the patient
Our goal is to help patients achieve healthy, sustainable weight loss while maintaining safety throughout treatment
However, gastrointestinal adverse effects (nausea, vomiting, diarrhea, constipation), unrealistic expectations, injection fatigue, drug availability, and inadequate counselling may also contribute